Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
about
How to Improve Therapeutic Ratio in Radiotherapy of HCCTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyRegulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Role of Akt signaling in resistance to DNA-targeted therapyBKM120 induces apoptosis and inhibits tumor growth in medulloblastomaCytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cellsPI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cellsXRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway.Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cellsFisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells.Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.
P2860
Q26738862-0C97CE64-A629-4F2A-B4D0-68ECE0D9641CQ26777016-2AE6B7BE-3F42-4EDD-8BFE-ABB11C38FB6EQ27330365-BEBAB48C-9B89-4674-BCB1-9B66C9D9C308Q28066950-F701B366-E8E1-4F7E-B9C6-69343F0CFD35Q33853264-78AADEFE-301C-4695-978F-A36F6264F695Q35176419-B3545F06-261F-499A-9216-DE5042ABD21AQ35833018-C2311FEA-733B-4167-8C00-CB1512003128Q36485168-8853D3A8-81B3-4DCF-9A41-5FD2F3F28539Q36544809-16784662-B826-4FDD-9AB3-E88632FAFED0Q36782266-738F2CA2-51DF-43BA-B241-19CB3C04DAC5Q37536691-9F6ADB6B-9FE8-41E1-B27F-677CE445BA88Q37679158-156AC973-81FE-4BB0-816E-B18B42C1875BQ41680129-B47A18C1-0099-494B-AF99-F1B559AEDC94Q42093380-E57D5875-4157-4B0F-9CE5-74169E0BC461Q49887903-6765FAB6-8F07-461D-8C7E-CF3ABE432A87
P2860
Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@ast
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@en
type
label
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@ast
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@en
prefLabel
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@ast
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@en
P2093
P2860
P356
P1433
P1476
Targeting Phosphatidylinositid ...... on in hepatocellular carcinoma
@en
P2093
Ann-Lii Cheng
Chiao-Ling Tsai
Feng-Ming Hsu
Jason Chia-Hsien Cheng
Wei-Lin Liu
P2860
P304
P356
10.18632/ONCOTARGET.1978
P407
P577
2014-06-01T00:00:00Z